EUVIMEDTutustu EUVIMEDiin
Crossref

High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain

Emily L Han iD, Dongyoon Kim iD, Amanda M Murray iD, Kaitlin Mrksich iD, Alex G Hamilton iD, Sophia Tang iD, Soyeon Yoo iD, Audrey T Zhu, Elaine R Tong, Rohan Palanki iD, Michelle L Hall, Sean K Bedingfield and 1 more

ACS Nano · 2026-02-03 · 20 (4) · 3807-3820

DOI: 10.1021/acsnano.5c19138 ↗

At a glance

Journal article in ACS Nano, published online on 2026-01-20. Written by Emily L Han and 12 co-authors. Institution: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Major MEDLINE topics: Lipids, RNA, Messenger, Nanoparticles, Brain. Cited 9 times so far (Crossref); 52 references. Funded by: Burroughs Wellcome Fund, Eli Lilly and Company, National Science Foundation.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Tiivistelmää ei ole saatavilla.

Subjects

MeSH terms (MEDLINE)

LipidsRNA, MessengerNanoparticlesBrainHigh-Throughput Screening AssaysAnimalsMiceBlood-Brain BarrierTransfectionPolyethylene GlycolsMice, Inbred C57BLLiposomes

Author keywords

braindrug deliverylipid nanoparticlesmRNAnanomedicine

Substances

LipidsRNA, MessengerLipid NanoparticlesPolyethylene GlycolsLiposomes

Authors and institutions

  • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Lilly Institute of Genetic Medicine, Eli Lilly & Company, Boston, Massachusetts 02210, United States.
  • Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

ORCID profiles: Emily L Han, Dongyoon Kim, Amanda M Murray, Kaitlin Mrksich, Alex G Hamilton, Sophia Tang, Soyeon Yoo, Rohan Palanki, Michael J Mitchell

Funding

  • Burroughs Wellcome Fund
  • Eli Lilly and Company
  • National Science Foundation

Cite

APA

Han, E. L., Kim, D., Murray, A. M., Mrksich, K., Hamilton, A. G., Tang, S., Yoo, S., Zhu, A. T., Tong, E. R., Palanki, R., Hall, M. L., Bedingfield, S. K., & Mitchell, M. J. (2026). High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain. ACS Nano, 20(4), 3807-3820. https://doi.org/10.1021/acsnano.5c19138

Vancouver

Han EL, Kim D, Murray AM, Mrksich K, Hamilton AG, Tang S, et al. High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain. ACS Nano. 2026;20(4):3807-3820. doi:10.1021/acsnano.5c19138

BibTeX
@article{Han2026,
  author = {Han, Emily L and Kim, Dongyoon and Murray, Amanda M and Mrksich, Kaitlin and Hamilton, Alex G and Tang, Sophia and Yoo, Soyeon and Zhu, Audrey T and Tong, Elaine R and Palanki, Rohan and Hall, Michelle L and Bedingfield, Sean K and Mitchell, Michael J},
  title = {High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {4},
  pages = {3807--3820},
  doi = {10.1021/acsnano.5c19138}
}
Start for free →